| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |